期刊文献+

黄芪甲甙对病毒性心肌炎小鼠心肌组织蛋白酶L表达的作用 被引量:9

Effect of astragaloside on the expression of cathepsin L in the myocardium with viral myocarditis
下载PDF
导出
摘要 目的探讨黄芪活性成分黄芪甲甙对病毒性心肌炎(VMC)小鼠心肌中组织蛋白酶L(cathepsinL,CL)表达的作用。方法BALB/C小鼠100只,随机分成6组。非感染小鼠腹腔无菌注射病毒培养液,分为正常对照组(A组10只,以羧甲基纤维素钠0.1ml灌胃7d)、9%黄芪甲甙对照组(B组10只,9%黄芪甲甙0.1ml灌胃7d);余80只小鼠以柯萨奇病毒(CVB3)腹腔无菌注射制作VMC模型,VMC小鼠随机分为心肌炎对照组和1%、3%、9%黄芪甲甙干预心肌炎组,分别以羧甲基纤维素钠及1%、3%、9%黄芪甲甙0.1ml灌胃7d(分别为C、D、E、F组,每组20只)。14d后处死全部小鼠并取其心脏。采用RT_PCR和免疫组化半定量检测心肌CLmRNA及蛋白表达水平。结果F组小鼠较C组死亡率明显降低[10%(2/20例)vs45%(9/20例),χ2=6.14,P<0.05],B组无小鼠死亡;与C组相比,CLmRNA、蛋白表达水平以及心肌病变积分在F组均显著下降,而1%、3%黄芪甲甙对心肌炎小鼠CLmRNA、蛋白表达及心肌病变积分无明显影响。结论黄芪甲甙可能通过抑制cathepsinL表达,对BALB/C小鼠CVB3心肌炎具有良好的治疗作用。 Objective To investigate the effect of astragaloside, one of the active components of astragalus monosome, on myocardial cathepsin L (CL) expression in murine model of coxsackievirus B (CVB3) myocarditis. Methods One hundred BALB/C mice were randomly divided into 6 groups. Group A (n = 10, treated with CMC 0.1 ml intragastric injection for 1 week) was served as normal control and group B(n = 10, treated with 9% astragaloside 0.1 ml ig for 1 week) as treatment control. The eighty infected animals treated with CMC and 1%, 3%, 9% astragaloside 0.1 ml ig for 1 week(n : 20 in each group) were served as group C, D, E, F, respectively. The mice were killed 14 days later and their hearts were removed for analysis. The levels of CL mRNA expression and protein in the myocardium were examined by RT-PCR and immunohistochemistry, respectively. Results The mortality was 10% (2/20) in 9% astragaloside treated infected animals (group F),which significantly reduced as compared to 45% (9/20) in group C (P〈0.05). In uninfected animals, 9% astragaloside did not cause any death. The levels of CL mRNA expression, protein and myocardial histopathologic scores in group F were significantly lower than those in group C. However, the CL expression and myocardial histopathologic scores were not influenced by 1% and 3% astragaloside. Conclusions Astragaloside may play a pivotal role in protecting the heart injury in BALB/C mice with CVB3 myocarditis by suppressing excessive expression of cathepsin L.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2006年第1期57-59,共3页 Journal of Clinical Pediatrics
基金 国家自然科学基金资助项目(编号:30271665)
关键词 心肌炎 病毒 组织蛋白酶L 黄芪甲甙 myocarditis virus cathepsin L astragaloside
  • 相关文献

参考文献6

  • 1Liu P,Mason JW. Advances in the understanding of myocarditis. Circulation,2001,104(9):1076-1082.
  • 2Collaborative Group of “Key National Medical Projects for the Ninth Five Year Plan Research” (Correspondence: YANG Yingzhen, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital,Shanghai Medical University,Shanghai 200032).急性病毒性心肌炎的药物治疗观察[J].中华心血管病杂志,1999,27(6):413-415. 被引量:94
  • 3Kishimoto C, Kawamata H, Sakai S, et al. Enhanced production of macrophage inflammatory protein 2(MIP-2) by in vitro and in vivo infections with encephalomyocarditis virus and modulation of myocarditis with an antibody against MIP-2. J Virol, 2001,75(3): 1294 - 1300.
  • 4Salvesen GS. A lysosomal protease enters the death scene. J Clin Invest, 2001,107(1) : 21 - 22.
  • 5Brunk UT, Neuzil J. Lysosomal involvement in apoptosis. Redox Rep,2001,6(2) :91 - 97.
  • 6杨英珍,熊丁丁.病毒性心肌炎治疗现状[J].中国新药与临床杂志,1998,17(5):307-309. 被引量:44

二级参考文献34

  • 1杨英珍.病毒性心肌炎进展(二)[J].中国中西医结合杂志,1995,15(9):557-561. 被引量:33
  • 2孙成文,江岩,钟国赣,战术,卫永弟,安占元.黄芪多糖抗氧化损伤作用的研究[J].中国药理学通报,1996,12(2):161-163. 被引量:114
  • 3陈瑞珍 杨英珍 等.急性病毒性心肌炎及其后遗心律失常的中西医结合治疗[J].中华实用中西医学,1998,1:91-93.
  • 4李延文 杨英珍 等.逆转录酶聚合酶链反应检测人血标本中肠道病毒核糖核酸[J].上海医科大学学报,1993,20:472-474.
  • 5宿燕岗 熊丁丁 等.牛磺酸对实验性小鼠病毒性心肌炎的疗效研究[J].中国心血管病杂志,1997,2:69-72.
  • 6陈瑞珍,中国新药与临床杂志,1998年,17卷,83页
  • 7杨英珍,Chin Med Sci J,1996年,11卷,89页
  • 8熊丁丁,上海医科大学学报,1996年,23卷,增刊,39页
  • 9顾薇,中国中西医结合杂志,1996年,16卷,713页
  • 10徐济民,临床实用新药手册,1996年,388页

共引文献131

同被引文献188

引证文献9

二级引证文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部